T. Rochat

Discipline

Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (7)

Co-auteur

Date

Source

Mot-clé

Human beings (6) maladie (5) Lungs (5) maladie (5) adulte (4) Patients (4) Diseases (4) Patients (4) adulte (4) risque (3) Diseases (3) Methods (3) Swiss (3) Risk (3) Hypertension (3) Older people (3) Methods (3) cohorte (3) thérapie (2) voie respiratoire (2) association (2) infection (2) effet (2) âge (2) Diagnosis (2) Treatment (2) Complications (2) Specimens (2) Cases (2) Genes (2)

Documents écrit par T. Rochat (7) | parle de T. Rochat (0)

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk.
G.B. Ehret et al. (2011)
Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients.
P.M. Soccal et al. (2010)
Decreased PM10 exposure attenuates age-related lung function decline: genetic variants in p53, p21, and CCND1 modify this effect.
M. Imboden et al. (2009)
Pulmonary hypertension in Switzerland: treatment and clinical course.
M. Fischler et al. (28 juin 2008)
Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study).
S. Ulrich et al. (20 oct. 2007)
A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection.
J. Garbino et al. (2006)
Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society.
E.W. Russi et al. (9 févr. 2002)